Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Frontage Holdings Corp. (HK:1521)
HKEX:1521
Holding HK:1521?
Track your performance easily
1521 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$0.47 - HK$2.33
Previous CloseHK$1.07
Volume1.03M
Average Volume (3M)5.56M
Market Cap
HK$2.18B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)45.7
Beta1.23
Next Earnings
Mar 31, 2025EPS Estimate
HK$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding2,053,513,910
10 Day Avg. Volume2,265,372
30 Day Avg. Volume5,560,794
Standard Deviation0.17
R-Squared0.35
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$1.57Price Target Upside46.73% Upside
Rating ConsensusHold
Number of Analyst Covering1
Frontage Holdings Corp. News
PremiumCompany Announcements
Frontage Holdings Boosts Talent with New Share Options
PremiumCompany Announcements
Frontage Holdings Reports Revenue Decline and Profit Turnaround
PremiumCompany Announcements
Frontage Holdings Strengthens Transaction Monitoring
PremiumCompany Announcements
Frontage Holdings Extends Key Services Agreement
PremiumCompany Announcements
Frontage Holdings Reports Mixed Mid-Year Results
PremiumCompany Announcements
Frontage Holdings Shareholders Approve Key ResolutionsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.48% Mutual Funds
― Other Institutional Investors
96.44% Public Companies and
Individual Investors
1521 FAQ
What was Frontage Holdings Corp.’s price range in the past 12 months?
Frontage Holdings Corp. lowest stock price was HK$0.47 and its highest was HK$2.33 in the past 12 months.
What is Frontage Holdings Corp.’s market cap?
Currently, no data Available
When is Frontage Holdings Corp.’s upcoming earnings report date?
Frontage Holdings Corp.’s upcoming earnings report date is Mar 31, 2025 which is in 128 days.
How were Frontage Holdings Corp.’s earnings last quarter?
Frontage Holdings Corp. released its earnings results on Aug 28, 2024. The company reported HK$0.023 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.023.
Is Frontage Holdings Corp. overvalued?
According to Wall Street analysts Frontage Holdings Corp.’s price is currently Undervalued.
Does Frontage Holdings Corp. pay dividends?
Frontage Holdings Corp. does not currently pay dividends.
What is Frontage Holdings Corp.’s EPS estimate?
Frontage Holdings Corp.’s EPS estimate is HK$0.08.
How many shares outstanding does Frontage Holdings Corp. have?
Frontage Holdings Corp. has 2,035,724,900 shares outstanding.
What happened to Frontage Holdings Corp.’s price movement after its last earnings report?
Frontage Holdings Corp. reported an EPS of HK$0.023 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.125%.
Which hedge fund is a major shareholder of Frontage Holdings Corp.?
Currently, no hedge funds are holding shares in HK:1521
---
Frontage Holdings Corp. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.80%
12-Months-Change
Fundamentals
Return on Equity
1.82%
Trailing 12-Months
Asset Growth
5.56%
Trailing 12-Months
Company Description
Frontage Holdings Corp.
Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical and development services. Geographically the group operates in both PRC and North America. The services provided in the North America segment, include Bioanalytical, CMC, DMPK and Safety and Toxicology services in the USA and Canada. The service offered in PRC includes Bioanalytical, Bioequivalence and CMC services in the PRC. Further, it also provides bioanalytical services, which are offered throughout the drug discovery and development process both in the United States and China.
---
1521 Stock 12 Month Forecast
Average Price Target
HK$1.57
▲(46.73% Upside)
Technical Analysis
Shanghai Haohai Biological Technology Co., Ltd. Class H
―
Viva Biotech Holdings
―
Pan Asia Data Holdings, Inc.
―
Sunac Services Holdings Ltd.
―
Best Analysts Covering 1521
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+25.70%
reiterated a sell rating 8 months ago
Copying Michael Luo CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.70% per trade.
---